Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Magnacal

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Calcium Carbonate 420
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2015
Label revision date
September 21, 2019
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Calcium Carbonate 420
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2015
Label revision date
September 21, 2019
Manufacturer
Afassco Inc.
Registration number
part331
NDC root
51532-0303
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be looking for a medication that helps relieve discomfort from various digestive issues. This drug is commonly used to alleviate symptoms associated with acid indigestion, sour stomach, heartburn, and upset stomach. It works by addressing these symptoms, providing you with relief when you experience digestive discomfort.

Uses

You can use this medication to help relieve several uncomfortable digestive symptoms. It is effective for managing acid indigestion, which is the uncomfortable feeling of too much acid in your stomach. If you experience a sour stomach, heartburn, or an upset stomach, this medication can also provide you with relief.

It's important to note that there are no reported teratogenic effects (which means it does not cause birth defects) or nonteratogenic effects associated with this medication. This makes it a safer option for those concerned about these specific risks.

Dosage and Administration

When taking this medication, adults and children aged 12 years and older can chew 2 or more tablets, but be careful not to exceed 18 tablets in a 24-hour period. It's important to follow this guideline to ensure safe use.

For children under 12 years old, you should not give this medication unless a doctor specifically directs you to do so. Always consult with a healthcare professional if you have any questions or concerns about the appropriate dosage for younger children.

What to Avoid

There are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

Before using this medication, it's important to consult with your doctor or health professional, especially if you are currently taking any prescription drugs, as antacids can interact with them. Additionally, you should not use the maximum dosage for more than two weeks unless directed by a physician.

Be aware that while using this medication, you may experience some side effects. If you notice any unusual symptoms or have concerns, it's best to reach out to your healthcare provider for guidance.

Warnings and Precautions

Before using this medication, it's important to consult with your doctor or a healthcare professional, especially if you are currently taking any prescription drugs, as antacids can interact with them. Additionally, do not exceed the maximum dosage for more than two weeks unless directed by your physician.

If you suspect an overdose, seek emergency medical help immediately or contact a Poison Control Center. Quick medical attention is crucial for both adults and children, even if there are no noticeable symptoms.

While there are no specific instructions to stop taking the medication, always stay in touch with your healthcare provider regarding any concerns or unusual symptoms you may experience.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have concerns about an overdose.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and your baby's well-being by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks to you and your baby. Always prioritize your health and your baby's well-being by seeking expert advice.

Pediatric Use

It's important to be cautious when considering medication for your child. If your child is under 12 years old, you should not give them this medication unless a doctor specifically instructs you to do so. Always consult with a healthcare professional to ensure the safety and appropriateness of any treatment for your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your kidney function might affect the use of this medication.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific condition. They can help determine the best approach based on your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

It's always best to discuss your liver condition with your healthcare provider before starting any new medication. They can provide personalized advice and ensure that your treatment is safe and effective for you.

Drug Interactions

It's important to be aware that antacids, which are commonly used to relieve heartburn and indigestion, can interact with some prescription medications. This means that taking antacids at the same time as certain drugs may affect how well those medications work.

To ensure your safety and the effectiveness of your treatment, always discuss any medications you are taking, including over-the-counter products like antacids, with your healthcare provider. They can help you understand potential interactions and adjust your treatment plan if necessary.

Storage and Handling

You can feel confident that there are no specific storage or handling instructions for this product or device. This means you can store it in a standard environment without any special requirements.

For safety, always handle the product with clean hands and ensure that any surfaces you use are clean. If you have any questions about proper use or safety, don’t hesitate to reach out for more information.

Additional Information

No further information is available.

FAQ

What symptoms does this drug relieve?

This drug is used for the relief of symptoms associated with acid indigestion, sour stomach, heartburn, and upset stomach.

What is the recommended dosage for adults and children over 12?

Adults and children aged 12 years and older should chew 2 or more tablets, not exceeding 18 tablets in a 24-hour period.

Can children under 12 use this drug?

Do not give this drug to children under 12 years of age unless directed by a doctor.

Are there any warnings before using this drug?

You should ask a doctor before use if you are taking a prescription drug, as antacids may interact with certain medications. Also, do not use the maximum dosage for more than 2 weeks without a physician's advice.

What should I do in case of an overdose?

In case of overdose, get medical help or contact a Poison Control Center immediately, as prompt medical attention is critical.

Is it safe to use this drug during pregnancy or breastfeeding?

If you are pregnant or breastfeeding, ask a health professional before using this drug.

Are there any contraindications for this drug?

There are no contraindications listed for this drug.

Packaging Info

Below are the non-prescription pack sizes of Magnacal (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Magnacal.
Details

Drug Information (PDF)

This file contains official product information for Magnacal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

AfasscoMagnacal12-16 is a chemical compound characterized by its specific molecular structure. The compound is utilized in various applications due to its unique properties. It is presented in a dosage form suitable for its intended use, ensuring optimal efficacy. The appearance of AfasscoMagnacal12-16 is consistent with its chemical nature, contributing to its functionality in professional settings.

Uses and Indications

This drug is indicated for the relief of symptoms associated with acid indigestion, sour stomach, heartburn, and upset stomach.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to chew 2 or more tablets, with a maximum dosage not to exceed 18 tablets within a 24-hour period. For children under 12 years of age, administration is not recommended unless specifically directed by a healthcare professional.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

It is imperative that healthcare professionals advise patients to consult with a physician or health professional prior to use if they are currently taking any prescription medications, as antacids may interact with certain drugs. Additionally, patients should be cautioned against using the maximum dosage of this product for more than two weeks unless directed by a physician.

In the event of an overdose, immediate medical assistance should be sought. Patients or caregivers are advised to contact a Poison Control Center without delay, as prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare providers should remain vigilant and encourage patients to discontinue use and seek medical advice if any concerning symptoms arise, although specific instructions for discontinuation were not provided in the available information.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. It is important to consult a healthcare professional before use, particularly if the patient is currently taking a prescription drug, as antacids may interact with certain medications.

Additionally, patients are advised not to exceed the maximum dosage for more than two weeks unless directed by a physician. This precaution is crucial to avoid potential complications or adverse effects that may arise from prolonged use at maximum dosages.

Monitoring for any unusual symptoms or reactions is recommended, and patients should seek medical advice if they have concerns regarding their treatment regimen.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Specifically, antacids can alter the gastric pH, which may impact the solubility and subsequent absorption of certain drugs.

Healthcare professionals should consider advising patients to space the administration of antacids and other medications by at least two hours to reduce the risk of interaction. This precaution is particularly important for drugs that have a narrow therapeutic index or those that are significantly affected by changes in gastric pH. Regular assessment of the patient's medication regimen is recommended to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Magnacal (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Magnacal.
Details

Pediatric Use

Pediatric patients under 12 years of age should not receive this medication unless specifically directed by a healthcare professional. Caution is advised when considering treatment in this age group, and healthcare providers should evaluate the necessity and appropriateness of therapy on a case-by-case basis.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider the potential risks associated with excessive administration of the medication.

It is essential to monitor patients closely for any signs or symptoms that may arise from an overdose. Symptoms may vary depending on the medication's pharmacological profile and the individual patient's response.

In the event of suspected overdosage, immediate medical intervention is recommended. Healthcare providers should initiate supportive care and symptomatic treatment as necessary. It is advisable to consult local poison control centers or relevant medical authorities for guidance on management protocols specific to the medication in question.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective management and follow-up care. Regular monitoring of vital signs and laboratory parameters may also be warranted to assess the patient's condition and guide further treatment decisions.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is essential to emphasize the importance of safety in the home environment, particularly for households with young children.

In the event of an overdose, healthcare providers should instruct patients to seek medical help or contact a Poison Control Center immediately. They should stress that prompt medical attention is critical for both adults and children, even if no signs or symptoms of overdose are apparent. This proactive approach can significantly impact the outcome in cases of accidental overdose.

Storage and Handling

The product is available in various package configurations, with specific NDC numbers assigned for identification. Storage and handling instructions are not explicitly provided; therefore, standard practices for pharmaceutical products should be followed. It is advisable to store the product in a controlled environment, ensuring that it is kept at appropriate temperature ranges to maintain its integrity. Containers should be kept sealed and protected from light and moisture to prevent degradation. Special handling requirements are not specified, but general precautions should be taken to ensure the product's quality and safety during storage and transportation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Magnacal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Magnacal, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.